Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» VelosBio
VelosBio
The top 10 largest biopharma M&A deals in 2020
The top 10 largest biopharma M&A deals in 2020
Fierce Pharma
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Gilead Sciences
Forty Seven
Merck
VelosBio
Nestle
Aimmune
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Bayer
Asklepios BioPharmaeutical
Flag link:
Astrazeneca shows megamergers were still possible in 2020
Astrazeneca shows megamergers were still possible in 2020
EP Vantage
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Bayer
Asklepios
Merck
VelosBio
Gilead Sciences
Forty Seven
Immunomedics
JNJ
Momenta
Flag link:
Merck inks $2.8B VelosBio buyout to snag anti-ROR1 ADC
Merck inks $2.8B VelosBio buyout to snag anti-ROR1 ADC
Fierce Biotech
Merck
VelosBio
M&A
antibody-drug conjugate
diffuse large B-cell lymphoma
Flag link:
VelosBio Emerges with $58M in Funding to Steer Cancer Drugs to Clinic
VelosBio Emerges with $58M in Funding to Steer Cancer Drugs to Clinic
Xconomy
cancer
VelosBio
Arix Bioscience
Flag link:
